May 4, 2026 04:38PM Karyopharm Therapeutics (KPTI) files $400M mixed shelf

Mar 30, 2026 09:04AM Karyopharm Therapeutics (KPTI) PT Lowered to $8 at Piper Sandler

Mar 25, 2026 06:55AM Karyopharm Therapeutics (KPTI) PT Lowered to $8 at H.C. Wainwright

Mar 24, 2026 02:52PM Karyopharm Therapeutics (KPTI) PT Lowered to $5 at Leerink Partners

Mar 24, 2026 10:35AM Increasing unusual option volume: KPTI TWO EWT CDNS DBA ORBS ACHV BOX

Mar 24, 2026 09:19AM RBC Capital defends Karyopharm Therapeutics (KPTI) amid 10pct premarket drop: 'We see upside potential'

Mar 24, 2026 07:18AM Karyopharm Therapeutics (KPTI) to resume trading at 7:30 am

Mar 24, 2026 06:57AM Karyopharm Therapeutics (KPTI) Halted, News Pending

Mar 23, 2026 04:52AM Karyopharm Therapeutics (KPTI) March 10 puts, April 10 puts, April 10 calls and April 17.50 calls active

Mar 18, 2026 05:56AM Increasing unusual call option volume: TME ORBS VSAT AIRS SMTC JBL SCO KPTI

Mar 16, 2026 10:41AM Increasing unusual put option volume: LW FXE BAM YOU TSEM LWLG COMP BIZD CWVX KPTI

Mar 9, 2026 04:16PM Rodman & Renshaw Starts Karyopharm Therapeutics (KPTI) at Buy, PT $28

Mar 6, 2026 06:54AM Karyopharm Therapeutics (KPTI) Reiterated at Overweight by Cantor Fitzgerald

Feb 12, 2026 02:23PM Karyopharm Therapeutics (KPTI) March 10 calls active, share price up 32%

Feb 12, 2026 07:45AM Karyopharm Therapeutics (KPTI) Misses Q4 EPS by 571c

Feb 5, 2026 12:36AM Cantor Fitzgerald Starts Karyopharm Therapeutics (KPTI) at Overweight

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 17, 2025 07:01AM Piper Sandler Highlights Karyopharm Therapeutics (KPTI) As a 2026 Top Pick

Nov 5, 2025 03:43PM RBC on Karyopharm Therapeutics (KPTI): 'we believe the reward/risk profile in shares...remains very attractive'

Nov 3, 2025 04:20PM Karyopharm Therapeutics (KPTI) files for 2.81M share offering by selling stockholders

Nov 3, 2025 04:16PM Karyopharm Therapeutics (KPTI) files for 9.57M share offering by selling stockholders

Oct 13, 2025 06:38AM H.C. Wainwright Upgrades Karyopharm Therapeutics (KPTI) to Buy

Oct 9, 2025 08:42AM Karyopharm Therapeutics (KPTI) PT Lowered at Piper Sandler Amid Financial Restructuring

Oct 8, 2025 03:17PM Karyopharm Therapeutics (KPTI) PT Lowered to $6 at Leerink Partners

Aug 11, 2025 10:59AM Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 432c

Jul 16, 2025 06:44AM H.C. Wainwright Downgrades Karyopharm Therapeutics (KPTI) to Neutral

Jul 11, 2025 07:33AM Karyopharm Therapeutics (KPTI) is further reducing its workforce by approximately 20%

May 13, 2025 09:44AM Karyopharm Therapeutics (KPTI) PT Lowered to $33 at RBC Capital

May 13, 2025 07:24AM Karyopharm Therapeutics (KPTI) Misses Q1 EPS by 251c

Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets

Mar 19, 2025 10:02AM Piper Sandler: 'Own Karyopharm Therapeutics (KPTI) for Myelofibrosis Data in 2H:25'; PT Split-Adjusted

Feb 24, 2025 08:41AM Karyopharm Therapeutics (KPTI) Announces 1:15 Reverse Share Split

Feb 20, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Karyopharm Therapeutics (KPTI)

Feb 19, 2025 07:33AM Karyopharm Therapeutics (KPTI) Tops Q4 EPS by 1c ; Offers Guidance

Jan 30, 2025 05:26PM Karyopharm increases authorized shares, approves reverse split

Jan 15, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Karyopharm Therapeutics (KPTI)

Jan 2, 2025 07:02AM Karyopharm Therapeutics (KPTI) Appoints Lori Macomber as CFO

Nov 20, 2024 04:06PM Karyopharm Therapeutics (KPTI) Appoints Kristin Abate as Chief Accounting Officer

Nov 6, 2024 07:57AM Karyopharm Therapeutics (KPTI) PT Raised to $5 at Piper Sandler

Nov 5, 2024 07:34AM Karyopharm Therapeutics (KPTI) Reports In-Line Q3 EPS ; Offers Guidance

Oct 31, 2024 07:31AM Karyopharm Therapeutics (KPTI) Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis

Aug 6, 2024 07:34AM Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 11c ; Offers Guidance

Jul 1, 2024 06:35AM Karyopharm Therapeutics (KPTI) PT Lowered to $7 at H.C. Wainwright

Jun 10, 2024 05:39AM RBC Capital Reiterates Outperform Rating on Karyopharm Therapeutics (KPTI)